Zeiss invests in Ocumeda to advance tele-ophthalmology platform with Fielmann Group

ByMAFO
Symbol picture. Image by Alexander Grey from Pixabay
Symbol picture. Image by Alexander Grey from Pixabay

Zeiss Vision Care announced the acquisition of a 10% stake in Ocumeda AG (“Ocumeda”) from the Fielmann Group for €10 million. Ocumeda’s current enterprise value totals €100 million. Zeiss Vision Care has the option to acquire up to 25% of the shares in further tranches.

Sven Hermann, Member of the Executive Board of the Zeiss Group, President and CEO of Zeiss Consumer Markets: “Our investment in Ocumeda underscores how important it is for us to protect and improve people’s vision and visual health. In Ocumeda, we have found an outstanding partner for this mission who shares our high standards of innovation and quality. As a future-proof platform provider in the Zeiss EyeCare Network, Ocumeda already plays a crucial role today and opens up opportunities for our customers to succeed in a business area with great potential and particular significance for consumers.”

Maximilian Foerst, Member of the Executive Board of the Zeiss Group and President and CEO of Zeiss Medical Technology: “At Zeiss Medical Technology, medical progress through innovative technologies and workflows is at the heart of what we do. An essential part of this is making eye care and eye health more accessible to everyone. Zeiss Vision Care’s decision to invest in Ocumeda underscores our strong commitment to innovation and accessibility.“

Marc Fielmann, CEO of the Fielmann Group: ”We are very pleased to welcome Zeiss Vision Care as a strategic investor in Ocumeda. Together, we will continue to expand Europe’s leading tele-ophthalmology platform, which is available to all patients, opticians, and ophthalmologists. This partnership is a significant milestone in the Fielmann Group’s Vision 2035, which aims to make eye care easily and quickly available. This is crucial to our mission of helping all people hear and see the beauty of the world.”

Benedikt Wiechers, CEO and founder of Ocumeda: “This investment is another important step in our mission to protect millions of people from vision loss. Zeiss Vision Care’s high standards of quality and innovation fit perfectly with our own values. Building on the strong foundation we have created with Fielmann, we will continue to significantly expand our network of opticians, optometrists, and ophthalmologists with Zeiss Vision Care, thereby meeting the growing global demand for low-threshold eye care.”